Skip to main content

Advertisement

SpringerLink
Log in

Atheroembolic renal disease associated with dabigatran overdose

  • Lessons for the Clinical Nephrologist
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Mayo RR, Swartz RD (1996) Redefining the incidence of clinically detectable atheroembolism. Am J Med 100(5):524–529

    Article  CAS  Google Scholar 

  2. Scolari F, Tardanico R, Zani R et al (2000) Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 36:1089–1109

    Article  CAS  Google Scholar 

  3. Modi KS, Rao VK (2001) Atheroembolic renal disease. J Am Soc Nephrol 12(8):1781–1787

    Article  Google Scholar 

  4. Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A, Cholesterol Embolism Study (CHEST) Investigators (2003) The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 42(2):211–216

    Article  Google Scholar 

  5. Bashore TM, Gehrig T (2003) Cholesterol emboli after invasive cardiac procedures. J Am Coll Cardiol 42(2):217–218

    Article  Google Scholar 

  6. Blankenship JC, Butler M, Garbes A (1995) Prospective assessment of cholesterol embolization in patients with acute myocardial infarction treated with thrombolytic vs conservative therapy. Chest 107:662–668

    Article  CAS  Google Scholar 

  7. Schwarz MW, McDonald GB (1987) Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction. JAMA 258:1934–1935

    Article  Google Scholar 

  8. Wong FK, Chan SK, Ing TS, Li CS (1995) Acute renal failure after streptokinase therapy in a patient with acute myocardial infarction. Am J Kidney Dis 26:508–510

    Article  CAS  Google Scholar 

  9. Meyrier A (2006) Cholesterol crystal embolism: diagnosis and treatment. Kidney Int 69:1308–1312

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina e Chirurgia, Scuola di Specializzazione di Nefrologia, Università degli Studi di Parma, Parma, Italy

    Maria Chiara Pacchiarini & Enrico Fiaccadori

  2. Unità Operativa di Nefrologia, Dipartimento di Medicina e Chirurgia, Azienda Ospedaliero-Universitaria di Parma, Università degli Studi di Parma, Via Gramsci 14, 43126, Parma, Italy

    Maria Chiara Pacchiarini, Enrico Fiaccadori & Giovanni Maria Rossi

  3. Laboratorio di Immunopatologia Renale “Luigi Migone”, Università degli Studi di Parma, Parma, Italy

    Giuseppe Vizzini, Chiara Italiano, Enrico Fiaccadori & Giovanni Maria Rossi

Authors
  1. Maria Chiara Pacchiarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Vizzini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chiara Italiano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Enrico Fiaccadori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giovanni Maria Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Maria Rossi.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

This research was performed in accordance with the ethical standards of the institutional research committee and with the declaration of Helsinki.

Research involving human participants and/or animals

This article does not contain any studies with animals or human participants performed by any of the authors. 

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 21 kb)

Supplementary file2 (TIF 58980 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pacchiarini, M.C., Vizzini, G., Italiano, C. et al. Atheroembolic renal disease associated with dabigatran overdose. J Nephrol 35, 1053–1057 (2022). https://doi.org/10.1007/s40620-021-01158-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-021-01158-z

Keywords

Search

Navigation